CAR-T, a therapy generally used in the treatment of cancer, has been shown to eliminate unhealthy cells that trigger autoimmunity in mouse models of multiple-sclerosis.
Researchers discover infants at higher risk of developing autism and who go on to be diagnosed with ASD experience hyper-expansion of brain surface areas between the ages of 6 - 12 months.
